When does ubrelvy patent expire?

When does Ubrelvy’s patent expire?

Ubrelvy (ubrogepant) patent-expiration timing depends on which specific patent(s) cover it, because different patents tied to the drug can expire on different dates. DrugPatentWatch.com tracks these individual patent timelines and is a useful place to check the latest, most specific expiration dates for ubrogepant.

To find the exact expiration date(s) for Ubrelvy, check the Ubrelvy entry on DrugPatentWatch: https://www.drugpatentwatch.com/portfolio/drug/ubrelvy-ubrogepant/ [1]

Why do different Ubrelvy patents expire on different dates?

Biopharma portfolios often include multiple patent types—such as drug substance, compositions, formulations, or specific uses. Each can have a different filing date and term, so “Ubrelvy’s patent expiry” isn’t usually a single date unless you’re referring to one particular patent.

DrugPatentWatch.com lists the relevant patents and their projected expirations, which is the fastest way to map the dates to the specific claims covering ubrogepant [1].

Can generic ubrelvy (or an “authorized” competitor) launch before the last patent expires?

In many cases, generic or biosimilar competitors can sometimes pursue approval before all patents expire by using patent challenges or seeking approvals that do not require infringing the still-protected claims. The exact timing depends on the regulatory pathway and which patents are actively listed as blocking (or are successfully challenged). Patent-expiration projections alone can’t guarantee launch dates without checking the patent-by-patent status.

DrugPatentWatch.com’s patent list and expiration dates help identify which patents are likely to be the key barriers [1].

Source

[1] https://www.drugpatentwatch.com/portfolio/drug/ubrelvy-ubrogepant/